GlassScriptPhysician profile
Alexandr L Abramov
NPI 1033211461
$807.92
in general payments reported to CMS, 2019-2025
11 companies · $227 in 2025
The $227 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.13 · 2021: $38.18 · 2022: $138 · 2023: $156 · 2024: $170 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $553.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $383.52 | 2019-2025 | Kristalose |
| Merck Sharp & Dohme LLC | $131.87 | 2019-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Sanofi Pasteur INC. | $77.35 | 2023-2024 | |
| Ars Pharmaceuticals Operations, INC. | $77.22 | 2025 | Neffy |
| Abbott Laboratories | $22.92 | 2025 | Freestyle Libre 3 |
| Cranial Technologies, INC | $21.78 | 2024 | Doc Band |
| Novo Nordisk INC | $20.49 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $19.43 | 2025 | Zoryve |
| Phadia US INC. | $19.42 | 2024 | Immunocap |
| Sobi, INC | $17.69 | 2021 | |
| Glaxosmithkline, LLC. | $16.23 | 2024 | Bexsero |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandr Abramov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.